![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C12Q 1/6886 |
(11) | Patento numeris | 2714937 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 12793322.4 |
Europos patento paraiškos padavimo data | 2012-05-31 | |
(97) | Europos patento paraiškos paskelbimo data | 2014-04-09 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2018-11-14 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2012/040183 |
Data | 2012-05-31 |
(87) | Numeris | WO 2012/166899 |
Data | 2012-12-06 |
(30) | Numeris | Data | Šalis |
201161493294 P | 2011-06-03 | US |
(72) |
FUNAHASHI, Yasuhiro, JP
KADOWAKI, Tadashi, JP
MATSUI, Junji, JP
SIMON, Jason S., US
XU, Lucy, US
|
(73) |
Eisai R&D Management Co., Ltd.,
6-10, Koishikawa 4-chome Bunkyo-ku, Tokyo 112-8088,
JP
|
(54) | BIOMARKERS FOR PREDICTING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS |
BIOMARKERS FOR PREDICTING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS |